← Medication Database
Oncology

Gleevec

Generic: imatinib

Manufacturer: Novartis  ·  Program: Novartis Patient Assistance Foundation

Apply for Assistance

Eligibility Criteria

Insurance Requirement

No private or public prescription coverage; exceptions for Medicare Part D or B cost-sharing if unaffordable

Residency

US resident

Income Threshold

Up to 500% FPL

Household income up to 500% FPL; varies by product and household size

Program Information

Processing Time

quick

Delivery Method

shipped to doctor's office or home

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • proof of residency
  • proof of income
  • prescription
  • proof of insurance status

Indicated For

CML, GIST

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Gleevec (Imatinib) at Low or No Cost ## About This Program The Novartis Patient Assistance Foundation (NPAF) helps eligible patients access Gleevec (imatinib) at no cost or reduced cost if they cannot afford their medication. Gleevec is a targeted cancer therapy used to treat certain types of leukemia and gastrointestinal stromal tumors. If you have been prescribed Gleevec and are struggling with the cost, this program may be able to help. ## Who Qualifies for NPAF To be eligible for the Novartis Patient Assistance Foundation program, you must meet all of the following requirements: - **Reside in the United States or a U.S. Territory** - **Have a valid prescription** for Gleevec from a licensed U.S. healthcare provider treating you on an outpatient basis - **Meet income guidelines** based on your household size (see income eligibility section below) - **Have limited or no prescription insurance coverage** (with specific exceptions for Medicare Part D or Part B cost-sharing if the medication is unaffordable) - **Not have insurance** associated with alternative funding programs that restrict or adjust coverage based on patient assistance program applications ## Income Eligibility Your household income must fall at or below **500% of the Federal Poverty Level (FPL)**, though the exact threshold may vary depending on your specific medication and household size. The income limits are based on your most recent federal tax return. | Household Size | 500% FPL (Approximate Annual Income) | |---|---| | 1 person | $68,750 | | 2 people | $92,250 | | 3 people | $115,750 | | 4 people | $139,250 | | 5+ people | Add $23,500 per additional person | *Note: These are approximate 2026 figures. Actual limits may vary. Visit www.PAP.Novartis.com to confirm current income requirements for Gleevec.* ## Insurance Requirements NPAF is designed for patients who are **uninsured or have government insurance** (such as Medicaid). If you have private prescription insurance, you generally do not qualify unless: - Your insurance has denied coverage for Gleevec - You have Medicare Part D or Part B and cannot afford the cost-sharing (copayments, coinsurance, or deductibles) - Your insurance is a government program If you have insurance, you must submit copies of your insurance card(s) (front and back) and any Prior Authorization denial letters with your application. ## Step-by-Step Application Process ### Step 1: Check Your Eligibility Visit **www.PAP.Novartis.com** to review detailed eligibility requirements for Gleevec and confirm your household income qualifies. ### Step 2: Gather Required Documentation Before starting your application, collect the following documents: - **Proof of income**: Copies of the first 2 pages of your most recent federal tax return (Form 1040). If you are not required to file taxes, contact NPAF directly at 1-800-277-2254. - **Insurance information**: Copies of the front and back of all insurance cards (primary, secondary, and prescription insurance) - **Valid prescription**: Your healthcare provider will submit this as part of their section - **Proof of residency**: Documentation showing you live in the U.S. or a U.S. Territory ### Step 3: Complete Your Section of the Application Fill out the patient section of the NPAF enrollment application form completely and accurately. Incomplete applications will result in processing delays or denial. You will need to: - Provide your personal information (name, address, date of birth, contact information) - List your household size and income - Provide insurance details - Sign and date the form to authorize NPAF to speak with your healthcare provider about your health condition ### Step 4: Have Your Healthcare Provider Complete Their Section Your prescribing physician must complete the healthcare provider section of the application, which includes: - Confirming your valid prescription for Gleevec - Providing medical information about your condition - Signing and dating their authorization - Submitting any Prior Authorization denial letters if applicable ### Step 5: Submit Your Complete Application Submit your completed application and all supporting documents via: **Fax**: 1-855-817-2711 **Mail**: Novartis Patient Assistance Foundation, Inc., P.O. Box 52029, Phoenix, AZ 85072-2029 Ensure all sections are completed and all required documents are attached before submitting. ## Timeline and Medication Delivery **Processing Time**: You will receive a decision letter within approximately **4 weeks** of submitting your complete application. If your application is incomplete, you will receive a letter with instructions on what additional information is needed. **Medication Delivery**: Once approved, your Gleevec will be shipped directly to your healthcare provider's office or to your home, depending on the program. **Text Message Updates**: If you opt in, you may receive text message updates about your application status. ## What Happens If Your Application Is Denied If your application is denied, you will receive a letter explaining the reason. Common reasons for denial include: - Incomplete application or missing documentation - Income exceeding program limits - Having insurance coverage that does not qualify for the program - Not meeting other eligibility criteria If you believe your application was denied in error, contact NPAF to discuss your options and whether you can reapply with additional information. ## Reauthorization and Ongoing Support Program eligibility is reviewed **every year**. You will need to reauthorize your participation in the program annually by submitting updated documentation, including: - Current proof of income (updated tax return or financial documentation) - Current insurance information - Confirmation that you still meet all eligibility requirements NPAF will notify you when reauthorization is required. ## Contact Information **Phone**: 1-800-277-2254 (Monday–Friday, 8:00 a.m. to 8:00 p.m. ET) **Website**: www.PAP.Novartis.com **Fax**: 1-855-817-2711 **Mailing Address**: Novartis Patient Assistance Foundation, Inc., P.O. Box 52029, Phoenix, AZ 85072-2029 ## Important Disclaimer This guide provides general information about the Novartis Patient Assistance Foundation program. Program details, income limits, and eligibility requirements may change. Always verify current requirements by visiting www.PAP.Novartis.com or calling 1-800-277-2254. This program is subject to all terms and conditions set by Novartis. Consult with your healthcare provider about whether this program is appropriate for your situation.

Program information last verified: March 30, 2026

Ready to apply for Gleevec assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications